Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Full Year Financial Performance
MCK logo

McKesson Hits Record $403.4 Billion Revenue Driven by 31% Growth in Oncology

MCK8-KFiling Date: 5/7/2026
McKesson Corporation
Description

What this story covers

McKesson Corporation achieved record fiscal 2026 revenues of $403.4 billion, a 12% increase fueled by specialty pharmaceuticals and oncology. The company reported an 18% jump in adjusted EPS, reflecting successful portfolio optimization and a strategic shift toward high-margin healthcare solutions.

Story snapshot

CompanyMcKesson Corporation
TickerMCK
VariantStandard detailed
Duration5:21
Filing type8-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0000927653-26-000066
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in